Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12Q - Measuring or testing processes involving enzymes or micro-organisms; Compositions or test papers therefor; Processes of preparing such compositions; Condition-responsive control in microbiological or enzymological processes › C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions
Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
12/2002
12/17/2002CA2185239C Isothermal strand displacement nucleic acid amplification
12/17/2002CA2085464C Using 5,10,15,10-tetrakis (r-carboxyphenyl)porphine for detecting and treating lung cancer
12/17/2002CA2047833C Cloning of the biosynthetic pathway genes for chlortetracycline production from streptomyces aureofaciens and their expression in steptomyces lividans
12/17/2002CA1341410C Recombinant acquired immune deficiency syndrome (aids) viral envelope protein and method of testing for aids
12/17/2002CA1341409C Cloning and expression of htlv-iii dna
12/15/2002CA2390670A1 Method of determining susceptibility to bipolar disorders
12/15/2002CA2390327A1 Method
12/15/2002CA2350846A1 Method of determining susceptibility to bipolar disorders
12/14/2002CA2390686A1 Cofactor-based screening method for nuclear receptor modulators and related modulators
12/13/2002CA2369717A1 Method for evaluating drug sensitivity
12/12/2002WO2002099437A1 Method of analyzing protein structure by mass spectroscopy
12/12/2002WO2002099436A2 Characterising polypeptides
12/12/2002WO2002099432A2 Quinacridone labelling reagents for fluorescence detection of biological materials
12/12/2002WO2002099429A1 Compositions and methods for the detection of biomarkers associated with cardiovascular disease
12/12/2002WO2002099428A1 Luciferin hydrazides
12/12/2002WO2002099427A1 Srpks as modifiers of the p53 pathway and methods of use
12/12/2002WO2002099426A1 Pecis as modifiers of the p53 pathway and methods of use
12/12/2002WO2002099424A2 Acridone derivatives as labels for fluorescence detection of target materials
12/12/2002WO2002099423A2 Method for determining an analyte
12/12/2002WO2002099421A2 Specific microarrays for breast cancer screening
12/12/2002WO2002099420A1 Diagnostic method based on lipid measuring parameter modulations/effector quotient profiles
12/12/2002WO2002099419A1 Composition and method for detecting an adulterant in an aqueous sample
12/12/2002WO2002099406A2 Single molecule detection systems and methods
12/12/2002WO2002099398A1 Methods and apparatus for characterization of single polymers
12/12/2002WO2002099387A2 Means and methods for monitoring protease inhibitor antiretroviral therapy and guiding therapeutic decisions in the treatment of hiv/aids
12/12/2002WO2002099386A2 Microcalorimetric detection of analytes and binding events
12/12/2002WO2002099385A2 Qtl controlling sclerotinia stem rot resistance in soybean
12/12/2002WO2002099383A2 Compositions and methods for evaluating viral receptor/co-receptor usage and inhibitors of virus entry using recombinant virus assays
12/12/2002WO2002099381A2 A single-cell biosensor for the measurement of gpcr ligands in a test sample
12/12/2002WO2002099141A1 Fluorescent quenching detection reagents and methods
12/12/2002WO2002099140A1 GLRAs AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE
12/12/2002WO2002099139A1 Modified microporous membrane for non-specific and sequence-specific nucleic acid capture and methods of use
12/12/2002WO2002099138A2 HS2STs AS MODIFIERS OF THE P53 PATHWAY AND METHODS OF USE
12/12/2002WO2002099137A1 Detection of single nucleotide polymorphisms
12/12/2002WO2002099135A1 Method to measure gene expression ratio of key genes
12/12/2002WO2002099134A1 Methods and compositions for assessment of pulmonary function and disorders
12/12/2002WO2002099133A1 Improved method for detecting and identifying microorganism causative of infection
12/12/2002WO2002099132A1 Method of analyzing transcriptional regulatory domain
12/12/2002WO2002099130A2 Virus detection using degenerate pcr primers
12/12/2002WO2002099129A2 Designing degenerate pcr primers
12/12/2002WO2002099128A2 Sequence independent identification of viruses
12/12/2002WO2002099127A1 Method for determining the presence of extension products
12/12/2002WO2002099126A1 Method for detecting single nucleotide polymorphisms (snp's) and point mutations
12/12/2002WO2002099125A1 PIBs AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE
12/12/2002WO2002099124A2 Characterising polypeptides
12/12/2002WO2002099123A1 Methods and kits for diagnosing a pancreatic-based fat malabsorption disorder
12/12/2002WO2002099122A1 Modifiers of the p53 pathway and methods of use
12/12/2002WO2002099118A2 Method of identifying a polymorphism in cyp2d6
12/12/2002WO2002099115A2 Nucleic acid-associated proteins
12/12/2002WO2002099108A2 Atp-binding cassette transporter-like molecules and uses thereof
12/12/2002WO2002099099A2 Polymorphisms in the human gene for cytochrome p450 polypeptide 2c8 and their use in diagnostic and therapeutic applications
12/12/2002WO2002099097A1 Novel compounds for chemiluminescense procedures
12/12/2002WO2002099088A1 Double-transfected cell line useful for the identification of transport inhibitors
12/12/2002WO2002099083A2 Gfats as modifiers of the p53 pathway and methods of use
12/12/2002WO2002099077A2 Methods and compositions related to tagging of membrane surface proteins
12/12/2002WO2002099075A2 Prmts as modifiers of the p53 pathway and methods of use
12/12/2002WO2002099074A2 Slc7s as modifiers of the p53 pathway and methods of use
12/12/2002WO2002099073A2 Method of assessing levels of infectious virus in a biological sample
12/12/2002WO2002099071A2 Hybridization normalization methods
12/12/2002WO2002099068A2 Lces as modifiers of the p53 pathway and methods of use
12/12/2002WO2002099063A2 Alteration of embryo/endosperm size during seed development
12/12/2002WO2002099060A2 Dgks as modifiers of the p53 pathway and methods of use
12/12/2002WO2002099059A2 U5-200KDs AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE
12/12/2002WO2002099058A2 KCNMAs AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE
12/12/2002WO2002099057A2 Sams modifiers of the p53 pathway and methods of use
12/12/2002WO2002099056A2 C22c7orfs as modifiers of the p53 pathway and methods of use
12/12/2002WO2002099055A2 Cips as modifiers of the p53 pathway and method of use
12/12/2002WO2002099054A2 Hccss as modifiers of the p53 pathway and methods of use
12/12/2002WO2002099053A2 Slc22as as modifiers of the p53 pathway and methods of use
12/12/2002WO2002099052A2 Opns as modifiers of the p53 pathway and methods of use
12/12/2002WO2002099051A2 Nits as modifiers of the p53 pathway and methods of use
12/12/2002WO2002099050A2 Tprs as modifiers of the p53 pathway and methods of use
12/12/2002WO2002099049A2 Tbc1d1s as modifiers of the p53 pathway and methods of use
12/12/2002WO2002099048A2 LIMKs AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE
12/12/2002WO2002099047A2 PROMLs AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE
12/12/2002WO2002099046A2 Spo11 as modifier of the p53 pathway and methods of use
12/12/2002WO2002099044A2 B3galts as modifiers of the p53 pathway and methods of use
12/12/2002WO2002099043A2 P5CRS AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE
12/12/2002WO2002099042A2 Cads as modifiers of the p53 pathway and methods of use
12/12/2002WO2002099041A2 Ces2s as modifiers of the p53 pathway and methods of use
12/12/2002WO2002099040A2 Igs as modifiers of the p53 pathway and methods of use
12/12/2002WO2002099038A2 Adsls as modifiers of the p53 pathway and methods of use
12/12/2002WO2002099036A2 Inhibition of neurodegeneration
12/12/2002WO2002099034A2 Sequences for detection and identification of methicillin-resistant staphyloccocus aureus
12/12/2002WO2002098916A2 Transcriptional regulator of genes involved in the control of cell growth or cell proliferation. use of said regulator as a therapeutic or diagnostic agent
12/12/2002WO2002098907A2 Cation conducting gabaa receptors and their use
12/12/2002WO2002098899A2 CHDs AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE
12/12/2002WO2002098898A2 FLJs AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE
12/12/2002WO2002098895A1 Nucleic acid amplification utilizing intermediate duplexes
12/12/2002WO2002098891A2 GADs AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE
12/12/2002WO2002098890A2 MARKs AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE
12/12/2002WO2002098889A2 MAP3Ks AS MODIFIER OF THE p53 PATHWAY AND METHODS OF USE
12/12/2002WO2002098885A1 Modified psma ligands and uses related thereto
12/12/2002WO2002098468A1 SLC13As AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE
12/12/2002WO2002098467A1 Slc2as as modifiers of the p53 pathway and methods of use
12/12/2002WO2002098458A1 Sphingosine kinase interacts with traf2 and modulates tumor necrosis factor-induced cellular activity
12/12/2002WO2002098444A2 Use of hepcidin for preparing a medicament for treating disorders of iron homeostasis
12/12/2002WO2002098358A2 Methods of diagnosis and treatment of androgen-dependent prostate cancer, prostate cancer undergoing androgen-withdrawal, and androgen-independent prostate cancer
12/12/2002WO2002098356A2 Ppp2cs as modifiers of the p53 pathway and methods of use
12/12/2002WO2002098355A2 Methods and reagents for diagnosis and treatment of insulin resistance and related conditions
1 ... 2197 2198 2199 2200 2201 2202 2203 2204 2205 2206 2207 2208 2209 2210 2211 2212 2213 2214 2215 2216 2217 ... 3003